Charlie Hospital Semarang Past Earnings Performance
Past criteria checks 2/6
Charlie Hospital Semarang has been growing earnings at an average annual rate of 24.9%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 25.4% per year. Charlie Hospital Semarang's return on equity is 0.5%, and it has net margins of 1.7%.
Key information
24.9%
Earnings growth rate
132.9%
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 25.4% |
| Return on equity | 0.5% |
| Net Margin | 1.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Charlie Hospital Semarang makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 47,332 | 786 | 9,609 | 0 |
| 31 Mar 24 | 45,104 | -191 | 7,293 | 0 |
| 31 Dec 23 | 42,160 | -1,112 | 9,020 | 0 |
| 30 Sep 23 | 40,154 | -1,177 | 7,395 | 0 |
| 31 Dec 22 | 33,033 | -7,355 | 8,055 | 0 |
| 31 Dec 21 | 35,558 | 2,740 | 7,982 | 0 |
| 31 Dec 20 | 13,264 | -3,883 | 4,697 | 0 |
Quality Earnings: RSCH has a high level of non-cash earnings.
Growing Profit Margin: RSCH became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RSCH has become profitable over the past 5 years, growing earnings by 24.9% per year.
Accelerating Growth: RSCH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: RSCH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-1.7%).
Return on Equity
High ROE: RSCH's Return on Equity (0.5%) is considered low.